Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 13 June, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 517206 | NSE: LUMAXIND

Lumax Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 13, 2025, 5:56 am

Market Cap 2,957 Cr.
Current Price 3,162
High / Low 3,300/1,960
Stock P/E21.1
Book Value 828
Dividend Yield1.11 %
ROCE16.4 %
ROE19.4 %
Face Value 10.0
PEG Ratio0.43

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Lumax Industries Ltd

Competitors of Lumax Industries Ltd

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Varroc Engineering Ltd 8,263 Cr. 541 717/36572.2 1020.00 %17.3 %7.48 % 1.00
Uravi T and Wedge Lamps Ltd 450 Cr. 412 670/254268 35.10.00 %10.2 %8.83 % 10.0
Lumax Industries Ltd 2,957 Cr. 3,162 3,300/1,96021.1 8281.11 %16.4 %19.4 % 10.0
Fiem Industries Ltd 4,979 Cr. 1,892 1,926/1,15624.6 3941.59 %27.8 %21.0 % 10.0
Industry Average4,162.25 Cr1,501.7596.48339.780.68%17.93%14.18%7.75

All Competitor Stocks of Lumax Industries Ltd

Quarterly Result

MetricMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
Sales 549512620579608618644632743766816887923
Expenses 492469560524559567589573677708755817844
Operating Profit 57436056495155586658617079
OPM % 10%8%10%10%8%8%9%9%9%8%8%8%9%
Other Income -191513141415132831211825
Interest 567891011131516191918
Depreciation 17192020212121242726262733
Profit before tax 35274841333438355246374253
Tax % 19%28%31%27%38%32%31%27%31%26%23%19%18%
Net Profit 29203330212326263634283344
EPS in Rs 30.5121.2035.2731.6022.2024.7328.0827.3738.5936.5730.2535.8247.04

Last Updated: May 31, 2025, 8:34 am

Below is a detailed analysis of the quarterly data for Lumax Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

  • For Sales, as of Mar 2025, the value is 923.00 Cr.. The value appears strong and on an upward trend. It has increased from 887.00 Cr. (Dec 2024) to 923.00 Cr., marking an increase of 36.00 Cr..
  • For Expenses, as of Mar 2025, the value is 844.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 817.00 Cr. (Dec 2024) to 844.00 Cr., marking an increase of 27.00 Cr..
  • For Operating Profit, as of Mar 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 70.00 Cr. (Dec 2024) to 79.00 Cr., marking an increase of 9.00 Cr..
  • For OPM %, as of Mar 2025, the value is 9.00%. The value appears strong and on an upward trend. It has increased from 8.00% (Dec 2024) to 9.00%, marking an increase of 1.00%.
  • For Other Income, as of Mar 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 18.00 Cr. (Dec 2024) to 25.00 Cr., marking an increase of 7.00 Cr..
  • For Interest, as of Mar 2025, the value is 18.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 19.00 Cr. (Dec 2024) to 18.00 Cr., marking a decrease of 1.00 Cr..
  • For Depreciation, as of Mar 2025, the value is 33.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27.00 Cr. (Dec 2024) to 33.00 Cr., marking an increase of 6.00 Cr..
  • For Profit before tax, as of Mar 2025, the value is 53.00 Cr.. The value appears strong and on an upward trend. It has increased from 42.00 Cr. (Dec 2024) to 53.00 Cr., marking an increase of 11.00 Cr..
  • For Tax %, as of Mar 2025, the value is 18.00%. The value appears to be improving (decreasing) as expected. It has decreased from 19.00% (Dec 2024) to 18.00%, marking a decrease of 1.00%.
  • For Net Profit, as of Mar 2025, the value is 44.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Dec 2024) to 44.00 Cr., marking an increase of 11.00 Cr..
  • For EPS in Rs, as of Mar 2025, the value is 47.04. The value appears strong and on an upward trend. It has increased from 35.82 (Dec 2024) to 47.04, marking an increase of 11.22.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 3:38 pm

MetricMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 1,2521,2711,6491,8511,6021,4261,7512,3202,6373,212
Expenses 1,1641,1701,5151,6981,4431,3261,6162,1122,4052,957
Operating Profit 89101135154158100135208231255
OPM % 7%8%8%8%10%7%8%9%9%8%
Other Income 417195719273517098
Interest 1311816222922304969
Depreciation 384148606465648093107
Profit before tax 416598134923353149159177
Tax % 10%16%27%23%22%45%23%31%30%
Net Profit 525471104721841103111132
EPS in Rs 55.6658.1676.34111.0376.9219.4243.56110.27118.77141.23
Dividend Payout % 22%25%30%32%31%36%31%24%29%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)3.85%31.48%46.48%-30.77%-75.00%127.78%151.22%7.77%
Change in YoY Net Profit Growth (%)0.00%27.64%15.00%-77.25%-44.23%202.78%23.44%-143.45%

Lumax Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2016-2017 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:%
5 Years:16%
3 Years:25%
TTM:29%
Compounded Profit Growth
10 Years:%
5 Years:14%
3 Years:38%
TTM:26%
Stock Price CAGR
10 Years:27%
5 Years:26%
3 Years:40%
1 Year:10%
Return on Equity
10 Years:%
5 Years:15%
3 Years:19%
Last Year:19%

Last Updated: Unknown

Balance Sheet

Last Updated: June 12, 2025, 3:09 pm

MonthMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital 9999999999
Reserves 259300353426437451482574662765
Borrowings 12792104140347338401431723888
Other Liabilities 4634787516154905646548521,2071,199
Total Liabilities 8598801,2171,1901,2831,3621,5461,8662,6012,861
Fixed Assets 4084195185496536277117499681,106
CWIP 1720345032474843178212
Investments 697988819092102147179246
Other Assets 3653625775105085966859271,2761,297
Total Assets 8598801,2171,1901,2831,3621,5461,8662,6012,861

Below is a detailed analysis of the balance sheet data for Lumax Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Mar 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 9.00 Cr..
  • For Reserves, as of Mar 2025, the value is 765.00 Cr.. The value appears strong and on an upward trend. It has increased from 662.00 Cr. (Mar 2024) to 765.00 Cr., marking an increase of 103.00 Cr..
  • For Borrowings, as of Mar 2025, the value is 888.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 723.00 Cr. (Mar 2024) to 888.00 Cr., marking an increase of 165.00 Cr..
  • For Other Liabilities, as of Mar 2025, the value is 1,199.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,207.00 Cr. (Mar 2024) to 1,199.00 Cr., marking a decrease of 8.00 Cr..
  • For Total Liabilities, as of Mar 2025, the value is 2,861.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,601.00 Cr. (Mar 2024) to 2,861.00 Cr., marking an increase of 260.00 Cr..
  • For Fixed Assets, as of Mar 2025, the value is 1,106.00 Cr.. The value appears strong and on an upward trend. It has increased from 968.00 Cr. (Mar 2024) to 1,106.00 Cr., marking an increase of 138.00 Cr..
  • For CWIP, as of Mar 2025, the value is 212.00 Cr.. The value appears strong and on an upward trend. It has increased from 178.00 Cr. (Mar 2024) to 212.00 Cr., marking an increase of 34.00 Cr..
  • For Investments, as of Mar 2025, the value is 246.00 Cr.. The value appears strong and on an upward trend. It has increased from 179.00 Cr. (Mar 2024) to 246.00 Cr., marking an increase of 67.00 Cr..
  • For Other Assets, as of Mar 2025, the value is 1,297.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,276.00 Cr. (Mar 2024) to 1,297.00 Cr., marking an increase of 21.00 Cr..
  • For Total Assets, as of Mar 2025, the value is 2,861.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,601.00 Cr. (Mar 2024) to 2,861.00 Cr., marking an increase of 260.00 Cr..

However, the Borrowings (888.00 Cr.) are higher than the Reserves (₹765.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +8110014010410376108108132212
Cash from Investing Activity +-37-62-128-97-194-31-129-90-245-293
Cash from Financing Activity +-59-39-11-696-5134-2613759
Net Cash Flow-15-2116-513-824-22

Free Cash Flow

MonthMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-38.009.0031.0014.00-189.00-238.00-266.00-223.00-492.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days535570443955484848
Inventory Days4552576175949196129
Days Payable135146180114131159163141154
Cash Conversion Cycle-36-39-53-9-17-9-24322
Working Capital Days-34-31-35-22-17241314
ROCE %19%24%22%17%8%11%19%17%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%
FIIs0.25%0.24%0.47%0.65%0.84%1.12%1.15%1.12%1.09%1.17%1.18%0.92%
DIIs0.36%0.30%0.56%0.57%0.62%1.03%1.27%1.42%1.46%1.57%3.56%4.94%
Public24.39%24.46%23.95%23.79%23.54%22.84%22.57%22.45%22.44%22.25%20.27%19.13%
No. of Shareholders22,42421,54219,71220,00120,08919,41019,74219,39519,32919,99918,88418,814

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Bandhan Transportation and Logistics Fund 37,000 1.86 10.2937,0002025-04-22 15:56:560%
HDFC Retirement Savings Fund - Hybrid Equity - Regular Plan 32,000 0.6 8.932,0002025-04-22 15:56:560%
Bank of India Manufacturing & Infrastructure Fund 18,882 1.3 5.2518,8822025-04-22 15:56:560%
Bandhan Hybrid Equity Fund 13,732 0.52 3.8213,7322025-04-22 14:36:320%
Bank of India Large & Mid Cap Equity Fund 10,138 0.81 2.8210,1382025-04-22 15:56:560%
Bank of India Large & Mid Cap Equity Fund - Eco Plan 10,138 0.81 2.8210,1382025-04-22 15:56:560%
Navi Large & Midcap Fund - Regular Plan 7,500 0.67 2.097,5002025-04-22 15:56:560%
HDFC Retirement Savings Fund - Hybrid Debt - Regular Plan 1,500 0.27 0.431,5002025-04-22 15:56:560%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 118.77110.2743.5719.4276.91
Diluted EPS (Rs.) 118.77110.2743.5719.4276.91
Cash EPS (Rs.) 155.92151.15104.5486.78131.96
Book Value[Excl.RevalReserv]/Share (Rs.) 718.41624.30526.06492.56477.62
Book Value[Incl.RevalReserv]/Share (Rs.) 718.41624.30526.06492.56477.62
Revenue From Operations / Share (Rs.) 2820.582481.381873.521525.491713.35
PBDIT / Share (Rs.) 258.66237.64158.72133.20176.62
PBIT / Share (Rs.) 159.33152.1590.6164.18108.65
PBT / Share (Rs.) 108.11114.9349.3733.7285.20
Net Profit / Share (Rs.) 56.5965.6636.4317.7763.98
NP After MI And SOA / Share (Rs.) 118.77110.2743.5719.4276.91
PBDIT Margin (%) 9.179.578.478.7310.30
PBIT Margin (%) 5.646.134.834.206.34
PBT Margin (%) 3.834.632.632.214.97
Net Profit Margin (%) 2.002.641.941.163.73
NP After MI And SOA Margin (%) 4.214.442.321.274.48
Return on Networth / Equity (%) 16.5317.668.283.9416.10
Return on Capital Employeed (%) 13.7617.8612.8010.6818.39
Return On Assets (%) 4.265.522.631.335.60
Long Term Debt / Equity (X) 0.220.100.110.000.05
Total Debt / Equity (X) 0.880.650.740.650.65
Asset Turnover Ratio (%) 1.181.421.241.111.34
Current Ratio (X) 0.790.780.690.630.58
Quick Ratio (X) 0.410.420.390.350.34
Inventory Turnover Ratio (X) 3.634.794.634.294.58
Dividend Payout Ratio (NP) (%) 22.7312.2416.0630.8968.25
Dividend Payout Ratio (CP) (%) 12.386.896.266.7836.23
Earning Retention Ratio (%) 77.2787.7683.9469.1131.75
Cash Earning Retention Ratio (%) 87.6293.1193.7493.2263.77
Interest Coverage Ratio (X) 5.057.576.934.377.53
Interest Coverage Ratio (Post Tax) (X) 2.103.283.391.583.73
Enterprise Value (Cr.) 2795.802030.761175.941796.461053.86
EV / Net Operating Revenue (X) 1.060.870.671.260.65
EV / EBITDA (X) 11.569.147.9314.436.38
MarketCap / Net Operating Revenue (X) 0.850.710.471.050.49
Retention Ratios (%) 77.2687.7583.9369.1031.74
Price / BV (X) 3.342.841.683.261.79
Price / Net Operating Revenue (X) 0.850.710.471.050.49
EarningsYield 0.040.060.040.010.08

After reviewing the key financial ratios for Lumax Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 118.77. This value is within the healthy range. It has increased from 110.27 (Mar 23) to 118.77, marking an increase of 8.50.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 118.77. This value is within the healthy range. It has increased from 110.27 (Mar 23) to 118.77, marking an increase of 8.50.
  • For Cash EPS (Rs.), as of Mar 24, the value is 155.92. This value is within the healthy range. It has increased from 151.15 (Mar 23) to 155.92, marking an increase of 4.77.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 718.41. It has increased from 624.30 (Mar 23) to 718.41, marking an increase of 94.11.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 718.41. It has increased from 624.30 (Mar 23) to 718.41, marking an increase of 94.11.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 2,820.58. It has increased from 2,481.38 (Mar 23) to 2,820.58, marking an increase of 339.20.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 258.66. This value is within the healthy range. It has increased from 237.64 (Mar 23) to 258.66, marking an increase of 21.02.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 159.33. This value is within the healthy range. It has increased from 152.15 (Mar 23) to 159.33, marking an increase of 7.18.
  • For PBT / Share (Rs.), as of Mar 24, the value is 108.11. This value is within the healthy range. It has decreased from 114.93 (Mar 23) to 108.11, marking a decrease of 6.82.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 56.59. This value is within the healthy range. It has decreased from 65.66 (Mar 23) to 56.59, marking a decrease of 9.07.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 118.77. This value is within the healthy range. It has increased from 110.27 (Mar 23) to 118.77, marking an increase of 8.50.
  • For PBDIT Margin (%), as of Mar 24, the value is 9.17. This value is below the healthy minimum of 10. It has decreased from 9.57 (Mar 23) to 9.17, marking a decrease of 0.40.
  • For PBIT Margin (%), as of Mar 24, the value is 5.64. This value is below the healthy minimum of 10. It has decreased from 6.13 (Mar 23) to 5.64, marking a decrease of 0.49.
  • For PBT Margin (%), as of Mar 24, the value is 3.83. This value is below the healthy minimum of 10. It has decreased from 4.63 (Mar 23) to 3.83, marking a decrease of 0.80.
  • For Net Profit Margin (%), as of Mar 24, the value is 2.00. This value is below the healthy minimum of 5. It has decreased from 2.64 (Mar 23) to 2.00, marking a decrease of 0.64.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 4.21. This value is below the healthy minimum of 8. It has decreased from 4.44 (Mar 23) to 4.21, marking a decrease of 0.23.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 16.53. This value is within the healthy range. It has decreased from 17.66 (Mar 23) to 16.53, marking a decrease of 1.13.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 13.76. This value is within the healthy range. It has decreased from 17.86 (Mar 23) to 13.76, marking a decrease of 4.10.
  • For Return On Assets (%), as of Mar 24, the value is 4.26. This value is below the healthy minimum of 5. It has decreased from 5.52 (Mar 23) to 4.26, marking a decrease of 1.26.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.22. This value is within the healthy range. It has increased from 0.10 (Mar 23) to 0.22, marking an increase of 0.12.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.88. This value is within the healthy range. It has increased from 0.65 (Mar 23) to 0.88, marking an increase of 0.23.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 1.18. It has decreased from 1.42 (Mar 23) to 1.18, marking a decrease of 0.24.
  • For Current Ratio (X), as of Mar 24, the value is 0.79. This value is below the healthy minimum of 1.5. It has increased from 0.78 (Mar 23) to 0.79, marking an increase of 0.01.
  • For Quick Ratio (X), as of Mar 24, the value is 0.41. This value is below the healthy minimum of 1. It has decreased from 0.42 (Mar 23) to 0.41, marking a decrease of 0.01.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.63. This value is below the healthy minimum of 4. It has decreased from 4.79 (Mar 23) to 3.63, marking a decrease of 1.16.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 22.73. This value is within the healthy range. It has increased from 12.24 (Mar 23) to 22.73, marking an increase of 10.49.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 12.38. This value is below the healthy minimum of 20. It has increased from 6.89 (Mar 23) to 12.38, marking an increase of 5.49.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 77.27. This value exceeds the healthy maximum of 70. It has decreased from 87.76 (Mar 23) to 77.27, marking a decrease of 10.49.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 87.62. This value exceeds the healthy maximum of 70. It has decreased from 93.11 (Mar 23) to 87.62, marking a decrease of 5.49.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 5.05. This value is within the healthy range. It has decreased from 7.57 (Mar 23) to 5.05, marking a decrease of 2.52.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.10. This value is below the healthy minimum of 3. It has decreased from 3.28 (Mar 23) to 2.10, marking a decrease of 1.18.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 2,795.80. It has increased from 2,030.76 (Mar 23) to 2,795.80, marking an increase of 765.04.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.06. This value is within the healthy range. It has increased from 0.87 (Mar 23) to 1.06, marking an increase of 0.19.
  • For EV / EBITDA (X), as of Mar 24, the value is 11.56. This value is within the healthy range. It has increased from 9.14 (Mar 23) to 11.56, marking an increase of 2.42.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.85. This value is below the healthy minimum of 1. It has increased from 0.71 (Mar 23) to 0.85, marking an increase of 0.14.
  • For Retention Ratios (%), as of Mar 24, the value is 77.26. This value exceeds the healthy maximum of 70. It has decreased from 87.75 (Mar 23) to 77.26, marking a decrease of 10.49.
  • For Price / BV (X), as of Mar 24, the value is 3.34. This value exceeds the healthy maximum of 3. It has increased from 2.84 (Mar 23) to 3.34, marking an increase of 0.50.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.85. This value is below the healthy minimum of 1. It has increased from 0.71 (Mar 23) to 0.85, marking an increase of 0.14.
  • For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 23) to 0.04, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Lumax Industries Ltd as of June 13, 2025 is: 2,741.57

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 13, 2025, Lumax Industries Ltd is Overvalued by 13.30% compared to the current share price 3,162.00

Intrinsic Value of Lumax Industries Ltd as of June 13, 2025 is: 4,076.95

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 13, 2025, Lumax Industries Ltd is Undervalued by 28.94% compared to the current share price 3,162.00

Last 5 Year EPS CAGR: 48.71%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 15.22%, which is a positive sign.
  2. The stock has a low average Working Capital Days of -11.78, which is a positive sign.
  3. The stock has a low average Cash Conversion Cycle of -18.00, which is a positive sign.
  4. The company has higher reserves (470.90 cr) compared to borrowings (359.10 cr), indicating strong financial stability.
  5. The company has shown consistent growth in sales (1.40 cr) and profit (100.10 cr) over the years.

    Stock Analysis

    • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Lumax Industries Ltd:
      1. Net Profit Margin: 2%
        • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
      2. ROCE: 13.76% (Industry Average ROCE: 17.93%)
        • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
      3. ROE%: 16.53% (Industry Average ROE: 14.18%)
        • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
      4. Interest Coverage Ratio (Post Tax): 2.1
        • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
      5. Quick Ratio: 0.41
        • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
      6. Stock P/E: 21.1 (Industry average Stock P/E: 96.48)
        • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
      7. Total Debt / Equity: 0.88
        • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
      The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
      Stock Rating:

    About the Company - Qualitative Analysis

    Lumax Industries Ltd. is a Public Limited Listed company incorporated on 10/12/1981 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1981PLC012804 and registration number is 012804. Currently Company is involved in the business activities of Manufacture of electric lighting equipment. Company's Total Operating Revenue is Rs. 3400.39 Cr. and Equity Capital is Rs. 9.35 Cr. for the Year ended 31/03/2025.
    INDUSTRYADDRESSCONTACT
    Auto Ancl - Equipment Lamp2nd Floor, Harbans Bhawan-II, New Delhi Delhi 110046lumaxshare@lumaxmail.com
    https://www.lumaxworld.in/lumaxindustries
    Management
    NamePosition Held
    Mr. Dhanesh Kumar JainChairman Emeritus
    Mr. Deepak JainChairman & Managing Director
    Mr. Anmol JainJoint Managing Director
    Mr. Tadayoshi AokiSenior Executive Director
    Mr. Raajesh Kumar GuptaExecutive Director
    Mr. Tomohiro KondoNon Executive Director
    Mr. Tetsuya HojoNon Executive Director
    Mr. Rajeev KapoorIndependent Director
    Ms. Ritika SethiIndependent Director
    Mr. Vikrampati SinghaniaIndependent Director
    Mr. Harish LakshmanIndependent Director
    Mr. Pradeep Singh JauharIndependent Director
    Ms. Pallavi Dinodia GuptaIndependent Director

    FAQ

    What is the intrinsic value of Lumax Industries Ltd?

    Lumax Industries Ltd's intrinsic value (as of 13 June 2025) is ₹2741.57 — 13.30% lower the current market price of 3,162.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 2,957 Cr. market cap, FY2025-2026 high/low of ₹3,300/1,960, reserves of 765 Cr, and liabilities of 2,861 Cr.

    What is the Market Cap of Lumax Industries Ltd?

    The Market Cap of Lumax Industries Ltd is 2,957 Cr..

    What is the current Stock Price of Lumax Industries Ltd as on 13 June 2025?

    The current stock price of Lumax Industries Ltd as on 13 June 2025 is 3,162.

    What is the High / Low of Lumax Industries Ltd stocks in FY 2025-2026?

    In FY 2025-2026, the High / Low of Lumax Industries Ltd stocks is ₹3,300/1,960.

    What is the Stock P/E of Lumax Industries Ltd?

    The Stock P/E of Lumax Industries Ltd is 21.1.

    What is the Book Value of Lumax Industries Ltd?

    The Book Value of Lumax Industries Ltd is 828.

    What is the Dividend Yield of Lumax Industries Ltd?

    The Dividend Yield of Lumax Industries Ltd is 1.11 %.

    What is the ROCE of Lumax Industries Ltd?

    The ROCE of Lumax Industries Ltd is 16.4 %.

    What is the ROE of Lumax Industries Ltd?

    The ROE of Lumax Industries Ltd is 19.4 %.

    What is the Face Value of Lumax Industries Ltd?

    The Face Value of Lumax Industries Ltd is 10.0.

    Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Lumax Industries Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE